Overview Financials News + Filings Key Docs Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Quarterly results
|
Monte Rosa Therapeutics, Inc.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/18/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
07/26/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
03/24/2023 |
3
| Skvarka Jan (Director) has filed a Form 3 on Monte Rosa Therapeutics, Inc. |
03/02/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
12/02/2021 |
3
| Jones Julian G (Chief Business Officer) has filed a Form 3 on Monte Rosa Therapeutics, Inc. |
06/23/2021 |
3
| Yang Rick (10% Owner) has filed a Form 3 on Monte Rosa Therapeutics, Inc. |
06/23/2021 |
3
| Walker Paul Edward (10% Owner) has filed a Form 3 on Monte Rosa Therapeutics, Inc. |
06/23/2021 |
3
| Sonsini Peter W. (10% Owner) has filed a Form 3 on Monte Rosa Therapeutics, Inc. |
06/23/2021 |
3
| SANDELL SCOTT D (10% Owner) has filed a Form 3 on Monte Rosa Therapeutics, Inc. |
06/23/2021 |
3
| Mathers Edward T (10% Owner) has filed a Form 3 on Monte Rosa Therapeutics, Inc. |
06/23/2021 |
3
| MAKOWER JOSHUA (10% Owner) has filed a Form 3 on Monte Rosa Therapeutics, Inc. |
06/23/2021 |
3
| Makhzoumi Mohamad (10% Owner) has filed a Form 3 on Monte Rosa Therapeutics, Inc. |
06/23/2021 |
3
| Landsman Liza (10% Owner) has filed a Form 3 on Monte Rosa Therapeutics, Inc. |
06/23/2021 |
3
| Florence Anthony A. Jr. (10% Owner) has filed a Form 3 on Monte Rosa Therapeutics, Inc. |
06/23/2021 |
3
| Chang Carmen (10% Owner) has filed a Form 3 on Monte Rosa Therapeutics, Inc. |
06/23/2021 |
3
| Behbahani Ali (10% Owner) has filed a Form 3 on Monte Rosa Therapeutics, Inc. |
06/23/2021 |
3
| BASKETT FOREST (10% Owner) has filed a Form 3 on Monte Rosa Therapeutics, Inc. |
06/23/2021 |
3
| New Enterprise Associates 17, L.P. (10% Owner) has filed a Form 3 on Monte Rosa Therapeutics, Inc. |
06/23/2021 |
3
| Mayweg Alexander (Director) has filed a Form 3 on Monte Rosa Therapeutics, Inc. |
06/23/2021 |
3
| Siu Christine (Director) has filed a Form 3 on Monte Rosa Therapeutics, Inc. |
06/23/2021 |
3
| Tamboli Ajim (CFO) has filed a Form 3 on Monte Rosa Therapeutics, Inc. |
06/23/2021 |
3
| SCHIFF ANDREW N (Director) has filed a Form 3 on Monte Rosa Therapeutics, Inc. |
06/23/2021 |
3
| Bolzon Bradley J PhD (10% Owner) has filed a Form 3 on Monte Rosa Therapeutics, Inc. |
06/23/2021 |
3
| Leo Chandra P. (Director) has filed a Form 3 on Monte Rosa Therapeutics, Inc. |
06/23/2021 |
3
| Castle John C. (Chief Data Scientist) has filed a Form 3 on Monte Rosa Therapeutics, Inc. |
06/23/2021 |
3
| Janku Filip (Chief Medical Officer) has filed a Form 3 on Monte Rosa Therapeutics, Inc. |
06/23/2021 |
3
| Blackwell Kimberly (Director) has filed a Form 3 on Monte Rosa Therapeutics, Inc. |
06/23/2021 |
3
| Warmuth Markus (See Remarks) has filed a Form 3 on Monte Rosa Therapeutics, Inc. |
06/23/2021 |
3
| Wallace Owen B. (Chief Scientific Officer) has filed a Form 3 on Monte Rosa Therapeutics, Inc. |
06/23/2021 |
3
| Townson Sharon (Chief Technology Officer) has filed a Form 3 on Monte Rosa Therapeutics, Inc. |
06/23/2021 |
3
| Versant Venture Capital VI, L.P. (10% Owner) has filed a Form 3 on Monte Rosa Therapeutics, Inc. |
06/23/2021 |
3
| Cormorant Asset Management, LP (10% Owner) has filed a Form 3 on Monte Rosa Therapeutics, Inc. |
|
|